Paper29376136
Clinical and molecular sub-classification of hepatocellular carcinoma relative to alpha-fetoprotein level in an Asia-Pacific island cohort.
Nishioka ST and 4 others. Hepatoma Res, 2018. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Clinical and molecular sub-classification of hepatocellular carcinoma relative to alpha-fetoprotein level in an Asia-Pacific island cohort. Papers, record 29376136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29376136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Clinical and molecular sub-classification of hepatocellular carcinoma relative to alpha-fetoprotein level in an Asia-Pacific island cohort.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA071789 | NCI NIH HHS | United States | P30CA071789 | PubMed and NIH | NIH RePORTER |
| R01 CA161209 | NCI NIH HHS | United States | R01CA161209 | PubMed and NIH | NIH RePORTER |
| U54 MD007584 | NIMHD NIH HHS | United States | U54MD007584 | PubMed and NIH | NIH RePORTER |
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25220842 | Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. | Int J Cancer | 2015 | https://conductscience.org/library/papers/25220842 | PubMed |
| 2 | 16199517 | Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. | Proc Natl Acad Sci U S A | 2005 | https://conductscience.org/library/papers/16199517 | PubMed |
| 3 | 19362088 | Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma. | Gastroenterology | 2009 | https://conductscience.org/library/papers/19362088 | PubMed |
| 4 | 26213370 | Heterogeneity of liver cancer and personalized therapy. | Cancer Lett | 2016 | https://conductscience.org/library/papers/26213370 | PubMed |
| 5 | 24832180 | Low alpha-fetoprotein HCC and the role of GGTP. | Int J Biol Markers | 2014 | https://conductscience.org/library/papers/24832180 | PubMed |
| 6 | 18316609 | EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. | Cancer Res | 2008 | https://conductscience.org/library/papers/18316609 | PubMed |
| 7 | 17187432 | Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. | Hepatology | 2007 | https://conductscience.org/library/papers/17187432 | PubMed |
| 8 | 28499413 | Ranking metrics in gene set enrichment analysis: do they matter? | BMC Bioinformatics | 2017 | https://conductscience.org/library/papers/28499413 | PubMed |
| 9 | 26617981 | Molecular classification of hepatocellular carcinoma: potential therapeutic implications. | Hepat Oncol | 2015 | https://conductscience.org/library/papers/26617981 | PubMed |
| 10 | 27732875 | Alpha-foetoprotein (AFP): A multi-purpose marker in hepatocellular carcinoma. | Clin Chim Acta | 2016 | https://conductscience.org/library/papers/27732875 | PubMed |
| 11 | 26058462 | Clinicopathological indices to predict hepatocellular carcinoma molecular classification. | Liver Int | 2016 | https://conductscience.org/library/papers/26058462 | PubMed |
| 12 | 20503898 | Hepatocellular cancer: risk factors and survival in Pacific Islanders compared to Caucasians in Hawaii. | Ethn Dis | 2010 | https://conductscience.org/library/papers/20503898 | PubMed |
| 13 | 26546044 | Alpha-fetoprotein is a biomarker of unfolded protein response and altered proteostasis in hepatocellular carcinoma cells exposed to sorafenib. | Cancer Lett | 2016 | https://conductscience.org/library/papers/26546044 | PubMed |
| 14 | 11799067 | E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. | Genes Dev | 2002 | https://conductscience.org/library/papers/11799067 | PubMed |
| 15 | 18701503 | Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. | Cancer Res | 2008 | https://conductscience.org/library/papers/18701503 | PubMed |
| 16 | 26995632 | Personalized therapy for hepatocellular carcinoma: Where are we now? | Cancer Treat Rev | 2016 | https://conductscience.org/library/papers/26995632 | PubMed |
| 17 | 15349906 | Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. | Hepatology | 2004 | https://conductscience.org/library/papers/15349906 | PubMed |
| 18 | 26213619 | Personalized management of hepatocellular carcinoma based on molecular information: future prospects. | Clin Liver Dis (Hoboken) | 2015 | https://conductscience.org/library/papers/26213619 | PubMed |
| 19 | 25362482 | Trans-ancestry mutational landscape of hepatocellular carcinoma genomes. | Nat Genet | 2014 | https://conductscience.org/library/papers/25362482 | PubMed |
| 20 | 18505921 | Gene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases. | Mol Cancer Res | 2008 | https://conductscience.org/library/papers/18505921 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35978665 | Second-line treatment of advanced hepatocellular carcinoma: Time for more individualized treatment options? | World J Hepatol | 2022 | https://conductscience.org/library/papers/35978665 | PubMed |
| 35699406 | The advanced development of molecular targeted therapy for hepatocellular carcinoma. | Cancer Biol Med | 2022 | https://conductscience.org/library/papers/35699406 | PubMed |
| 35360522 | R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation. | JHEP Rep | 2022 | https://conductscience.org/library/papers/35360522 | PubMed |
| 35052777 | Autoantibody to GNAS in Early Detection of Hepatocellular Carcinoma: A Large-Scale Sample Study Combined with Verification in Serial Sera from HCC Patients. | Biomedicines | 2022 | https://conductscience.org/library/papers/35052777 | PubMed |
| 35002508 | The Landscape Of Alpha Fetoprotein In Hepatocellular Carcinoma: Where Are We? | Int J Biol Sci | 2022 | https://conductscience.org/library/papers/35002508 | PubMed |
| 34484865 | Integrated analysis of the rhesus monkey liver transcriptome during development and human primary HCC AFP-related gene expression. | Mol Ther Nucleic Acids | 2021 | https://conductscience.org/library/papers/34484865 | PubMed |
| 33748017 | Association of Postoperative Biomarker Response with Recurrence and Survival in Patients with Hepatocellular Carcinoma and High Alpha-Fetoprotein Expressions (>400 ng/ml). | J Hepatocell Carcinoma | 2021 | https://conductscience.org/library/papers/33748017 | PubMed |
| 33290597 | Molecular subtyping of hepatocellular carcinoma: A step toward precision medicine. | Cancer Commun (Lond) | 2020 | https://conductscience.org/library/papers/33290597 | PubMed |
| 32374744 | Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma. | PLoS One | 2020 | https://conductscience.org/library/papers/32374744 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AFP | 174 | PubTator's text mining | https://conductscience.org/library/genes/174 | NCBI Gene |
| EPCAM | 4072 | PubTator's text mining | https://conductscience.org/library/genes/4072 | NCBI Gene |
| MYC | 4609 | PubTator's text mining | https://conductscience.org/library/genes/4609 | NCBI Gene |
| TENM1 | 10178 | PubTator's text mining | https://conductscience.org/library/genes/10178 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29376136
GET https://conductscience.org/api/papers/v1/29376136/references?page=2